Table 1.
Description of case and control groups.
Table 2.
Proportion of tumor size categories in case and control groups.
Table 3.
Proportion of grading features in case and control groups.
Table 4.
Distribution of ALN involvement in case and control groups.
Table 5.
Proportion of breast-conserving surgery (BCS) among molecular subtypes.
Table 6.
Distribution of molecular subtypes according to cases and controls.
Table 7.
Distribution of ALN involvement among molecular subtypes.
Table 8.
Distribution of ALN involvement according to luminal or non-luminal profiles.
Table 9.
Number and percentage of distant metastases per molecular subtypes.
Table 10.
Associated risk of distant metastases among molecular subtypes.
Table 11.
Binomial distribution of molecular subtypes into luminal/non-luminal and HER2-positive/HER2-negative profiles in the case group compared to controls.
Table 12.
Frequency of metastases associated with sites of breast cancer relapse.
Table 13.
Frequency of distant organ involvement by each breast cancer subtype.
Table 14.
Organ-specific metastatic risk according to binomial distribution of molecular subtypes into luminal/non-luminal profiles.
Table 15.
Organ-specific metastatic risk according to binomial distribution of molecular subtypes into HER2-positive/HER2-negative profiles.